BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/3/2025 9:10:07 AM | Browse: 123 | Download: 296
 |
Received |
|
2025-07-06 13:25 |
 |
Peer-Review Started |
|
2025-07-06 13:25 |
 |
First Decision by Editorial Office Director |
|
2025-08-08 09:21 |
 |
Return for Revision |
|
2025-08-08 09:21 |
 |
Revised |
|
2025-08-22 02:12 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-10-27 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-10-27 06:08 |
 |
Articles in Press |
|
2025-10-27 06:08 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-11-21 08:52 |
 |
Publish the Manuscript Online |
|
2025-12-03 09:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Walaa Abdelhamed, Mona Amin, Imam Waked and Mohamed El-Kassas |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed El-Kassas, Department of Endemic Medicine, Faculty of Medicine, Helwan University, Ain Helwan, Cairo 11795, Egypt. m_elkassas@med.helwan.edu.eg |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Egypt; Epidemiology; Risk factors; Obesity; Prevalence; Non-invasive diagnostics; Management |
| Core Tip |
Egypt faces one of the highest metabolic dysfunction-associated steatotic liver disease (MASLD) burdens globally, yet disease awareness and access to care remain critically limited. Recognizing MASLD as a national health priority and integrating it into non-communicable disease strategies through population-based screening, lifestyle interventions, and provider education, offers a scalable model for other high-risk, resource-constrained settings. |
| Publish Date |
2025-12-03 09:10 |
| Citation |
Abdelhamed W, Amin M, Waked I, El-Kassas M. Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges. World J Gastroenterol 2025; 31(45): 111643 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i45/111643.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i45.111643 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.